Results 121 to 130 of about 2,974 (211)

Rational construction of a high-quality and high-efficiency biosynthetic system and fermentation optimization for A82846B based on combinatorial strategies in Amycolatopsis orientalis

Microbial Cell Factories
Background Oritavancin is a new generation of semi-synthetic glycopeptide antibiotics against Gram-positive bacteria, which served as the first and only antibiotic with a single-dose therapeutic regimen to treat ABSSSI. A naturally occurring glycopeptide
Xinyi Zhao, Chenyang Zhu, Wenli Gao, Huang Xie, Zhongyuan Lyu, Qingwei Zhao, Yongquan Li   +6 more
doaj   +1 more source

A new assay to determine Oritavancin concentrations [PDF]

The Journal of Antibiotics, 2010
Céline, Vidaillac, Jeffrey R, Aeschlimann, Michael J, Rybak   +2 more
openaire   +2 more sources

Off-label use of oritavancin: a case series on clinical effectiveness, bed-day savings and cost benefits. [PDF]

JAC Antimicrob Resist
Patel A, Walden A, Iyer S, Okoibhole A.
europepmc   +1 more source

Oritavancin as rescue therapy in severe methicillin-resistant Staphylococcus aureus pneumonia: A case report. [PDF]

Respir Med Case Rep
Virzì F, Giacopelli G, Tutone P, Tomasello S.   +3 more
europepmc   +1 more source

A SERS-based biosensor for optical monitoring of PARP1 trapping dynamics and high-throughput screening of modulators. [PDF]

J Nanobiotechnology
Xu S, Wang Z, Li B, Wang J, Fang S, Huang W, Liu Z, Li H, Xiang J, Xu S, Liang C.   +10 more
europepmc   +1 more source

New antibiotics for bad bugs: where are we? [PDF]

core   +1 more source

Cardiac Implantable Electronic Device-Related Infective Endocarditis Caused by <i>Bacillus cereus</i>: A Case Report. [PDF]

J Clin Med
Swolana D, Łoboda D, Sarecka-Hujar B, Sznajder R, Szajerska-Kurasiewicz A, Zębik T, Gołba KS, Wojtyczka RD.   +7 more
europepmc   +1 more source

ORItavancin as a therapeutic regimen for Cardiac Implantable Electronic Devices infections with multidrug-resistant Gram-positive cocci (ORI-4-CIEDi) pilot study: rationale and design. [PDF]

Cardiol J
Łoboda D, Swolana D, Joniec M, Gładysz-Wańha S, Gibiński M, Simionescu K, Piłat E, Gołba KS, Wojtyczka RD, Wilczyński S, Sarecka-Hujar B.   +10 more
europepmc   +1 more source

The Use of Oritavancin as Consolidation Therapy for Infective Endocarditis Caused by <i>Enterococcus</i> spp. [PDF]

Open Forum Infect Dis
Frondizi F, Leanza GM, Chiuchiarelli M, Catania F, Sangiorgi F, Giovannenze F, Taddei E, Tamburrini E, Torti C, Scoppettuolo G.   +9 more
europepmc   +1 more source

Are Oritavancin and Dalbavancin More Cost Effective for Outpatient Parenteral Antimicrobial Therapy at a Veterans Affairs Medical Center? [PDF]

Fed Pract
Hanks D, Jodlowski TZ, Madaras-Kelly K, Diaz J, Vietri N.   +4 more
europepmc   +1 more source